HIGHLIGHTS
- who: (ABR and collaborators from the Department of Otolaryngology, the Second Hospital of Hebei Medical University, No, Heping West Road, Shijiazhuang, Hebei, China have published the Article: Agmatine alleviates cisplatin-induced ototoxicity by activating PI3K/AKT signaling pathway, in the Journal: (JOURNAL)
- what: The investigation demonstrates that agmatine pre-treatment could alleviate cisplatin-induced ototoxicity with the activation of PI3K/AKT signaling pathway. cochlear explants (DPOAE) and showed auditory increased brainstem ROS production response In summation, the authors demonstrate that agmatine significantly affects the protection against cisplatin-induced ototoxicity by inhibiting ROS production and mitochondrial . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.